Rodrigo Assar/LinkedIn
Dec 13, 2025, 08:39
Rodrigo Assar: Nine Groundbreaking Articles – Frontiers in Thrombosis and Hemostasis
Rodrigo Assar, Senior Data Scientist at Globant, shared a post on LinkedIn:
“Exciting news!
I’m thrilled to share that we have published **nine groundbreaking articles** in our research topic on **Innovative Modeling and Simulation in Thrombosis and Hemostasis** at Frontiers.
We got 9 publications!
As an editor alongside Daria Hemmerling, it has been a pleasure to contribute to the advancement of science in this role. This project has been an engaging way to stay connected to research while enhancing diagnosis and treatment in our field.
Check out the articles here: [Frontiers in Thrombosis and Hemostasis].
Let’s continue pushing the boundaries of science together!”
Follow the latest in Hemostasis Today.
-
Aug 15, 2026, 19:30José Luis Neyro: E4 and DRSP Reduce Hirsutism While Showing Comparable Effects on Thrombin Generation
-
Aug 15, 2026, 19:27Mahmoud Akraym: Don’t Choose Anticoagulation as the Immediate Treatment for Unstable AF
-
Aug 15, 2026, 19:25Ahmed Bennis: DOACs Increase 1-Year Stroke Risk but Reduce MI Risk Compared With Warfarin
-
Aug 15, 2026, 19:24Megan Adediran: An Unwavering Fight for People Living With Haemophilia
-
Aug 15, 2026, 19:23Intravenous Anticoagulation Linked to Worse Early Outcomes After Noncardioembolic Stroke – International Journal of Stroke
-
Aug 15, 2026, 18:03Alejandro González Veliz: Pulmonary Embolism Is Not Always an Anticoagulation-Only Problem
-
Aug 15, 2026, 17:57Ayesha Zia: A New Foundation for Pediatric Pulmonary Embolism Research and Care
-
Aug 15, 2026, 17:50Muhammad Shaheer Bin Faheem: 25 Years of Thromboembolism and Hypertension Mortality
-
Aug 15, 2026, 17:21Bilal Salman։ NETosis as a Therapeutic Target in Inflammation and Thrombosis